Galectin‐3 in patients with heart failure with preserved ejection fraction: results from the Aldo‐DHF trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1879-0844|17|2|214-223

ISSN： 1388-9842

Source： EUROPEAN JOURNAL OF HEART FAILURE, Vol.17, Iss.2, 2015-02, pp. : 214-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

By de Boer Rudolf A.   Lok Dirk J. A.   Jaarsma Tiny   van der Meer Peter   Voors Adriaan A.   Hillege Hans L.   van Veldhuisen Dirk J.  

Annals of Medicine, Vol. 43, Iss. 1, 2011-02 ,pp. : 60-68

Informa Healthcare

Access to resources Recommend Favorite

Homocysteine Levels in Patients with Heart Failure with Preserved Ejection Fraction

By  

Cardiology, Vol. 117, Iss. 1, 2010-09 ,pp. : 21-27

Karger

Access to resources Recommend Favorite

Diagnosing heart failure with preserved ejection fraction

By Becher Peter Moritz   Lindner Diana   Fluschnik Nina   Blankenberg Stefan   Westermann Dirk  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 5, 2013-09 ,pp. : 463-474

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of Heart Failure with Preserved Ejection Fraction

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 4, 2015-04 ,pp. : 351-360

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heart failure with preserved ejection fraction: uncertainties and dilemmas

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 7, 2015-07 ,pp. : 665-671

John Wiley & Sons Inc

Access to resources Recommend Favorite